Introduction
The most common cause of portal hypertension is liver cirrhosis and other common causes are portal vein obstruction, idiopathies or it may associate with infection, pancreatitis or abdominal trauma. Also hematological malignancies and other hypercoagulable states are rarely related with portal vein thrombosis and portal hypertension. Antiphospholipid syndrome (APS) is a clinical syndrome consists of the presence of antiphospholipid antibodies (aPL) and a status of hypercoagulability [1, 2] . Intravascular thrombosis can arise in vessels of any size in any organ.
APS may be divided into several categories. Primary APS occurs in patients without clinical evidence of another disease, whereas secondary APS occurs in association with autoimmune disease, infection, cancer and the use of drugs or hemodialysis [1] .
We report a case of secondary APS related with systemic bacterial infection that complicated fundal variceal bleeding and ascites as a consequence of acute portal vein thrombosis.
Case
A 52-year-old man was admitted to our hospital because of chills, sweating and weight loss of 10 kg in one month. He complained of coughing and purulent sputum. He had no medical or family history of diabetes, liver diseases. He was a 20-packyear current smoker and social drinker. He was a cook in a Chinese restaurant. At admission, his blood pressure was 130/70 mmHg, pulse rate was 108/min, body temperature was 37.3 o C, respiratory rate was 22/min. His sclera was icteric and conjunctiva was anemic. Breathing sound was coarse and decreased on both lower lung fields and moist rales were heard on the left lower lung field. The abdomen was soft and slightly distended, and the liver and spleen were not palpable. The laboratory data on the admission were as follows: hemoglobin 10.1 g/dL, platelet Antiphospholipid antibody syndrome (APS) is characterized by raised levels of antiphospholipid antibodies (aPL), in association with thrombosis, recurrent fetal loss, and thrombocytopenia. Development of APS is related with idiopathic origin, autoimmune disease, malignancy and, on rare occasions, infection. However, in secondary APS combined with bacterial infections, aPL is usually shown with low titer and rarely associated with thrombotic events. A 52-year-old male was admitted due to pneumonia and multiple hepatosplenic abscesses. He had been treated with proper antibiotics, but he presented ascites and sudden variceal bleeding because of portal vein thrombosis. A simple X-ray showed collapsed consolidation on the left lower lung field and a air fluid level within a cavitary lesion on the left upper quadrant of the abdomen (Fig. 1) . The CT revealed a large splenic abscess, multiple liver abscesses, bronchopneumonia in left lung with left pleural effusion (Fig. 2) .
Case Report
Empiric antibiotics therapy with levofloxacin, amikacin sulfate and metronidazole was started, but the fever did not subside. (Fig. 4) . In order Many authors had reported raised levels of aPL in a variety infectious diseases [3] [4] [5] . Syphilis was the first infection to be linked to the aPL in 1983. And many other infections have been found to be associated with aPL positivity, but pathogenic role is not clear. HCV infection is usually not detected in patients with APS [3] , but, low levels of aPL may be found in patients with HCV infection and, rarely evoke thrombotic events [4, 6] .
The pathogenesis of thrombotic complications in HIV infected patients and patients with AIDS is multifactorial, with the aPL playing a role in selected patients only [5, 7] . Lipid disturbances consequent on antiretroviral treatment in AIDS may be prime causes of these complications. Other viral infections, including Epstein-Barr virus, varicella, cytomegalovirus, rubella virus were reported [2, 8] . However, in these cases, propensity for IgM-aPL is usually shown with low titer and presence of aPL is often transient and disappears after the treatment of the infection [1, 8] . Many bacterial infections demonstrate aPL. However, these increases in aPL are usually not associated with thrombotic events. Microvascular thromboses in the absence of vascular wall inflammation is a rare manifestation of leprosy, and this type of leprosy was associated with aPL [5] . aPL may also be associated with Mycoplasma pneumoniae, bacterial endocarditis and Salmonella infections were reported, but there has been some controversy about overt clinical manifestations [5] .
Recently, the infectious origin of APS was proven to be one of the explanations for the generation of anti-beta-2-glycoprotien I (β2GPI) antibodies by sharing molecular mimicry with common bacteria [2, [8] [9] [10] [11] . The human β2GPI molecule, a plasma protein, has anticoagulant properties in vitro which are inhibition of prothrombinase activity, ADP-induced platelet aggregation, and platelet factor IX production [8] . Most previous reports showed a high prevalence of arterial thrombosis, while portal vein thrombosis in APS has been less commonly reported and these cases were not combined infections, unlike the present case [13] . Portal vein thrombosis can occur in intra-abdominal infections, as pancreatitis, cholangitis, portal vein phlebitis and intra-abdominal abscess. In previous reports, Bacteroides bacteremia in patients with pylephlebitis suggests that the thrombogenic nature of the organism plays an integral role in the pathogenesis of septic thrombophlebitis [14] .
Bacteroides species produce heparinase which may injure normal endotherial tissue in gastrointestinal organs [15] . And the lipopolysaccharide isolated from Bacteroides species accelerated coagulation in mice and activated Hageman factor [16] . These activations can play a role in promoting intravascular thrombosis.
There is no proven data, in APS, that anaerobic bacteria trigger thrombosis. But there is a case report that showed portal vein thrombosis with anaerobe Bacteroides induced pyelophlebitis and transient elevation of IgM aPL [17] .
Our case is unique because anaerobe induced intra-abdominal abscess complicated overt APS that IgG aPL was detected and sustained after treatment and produced portal vein thrombosis and complicated variceal bleeding and massive ascites. We used low molecular heparin instead of oral anticoagulants for resolving portal vein thrombosis in order to avoid drug interaction between warfarin and metronidazole. However, in case of secondary APS associated with infection, intensity of anticoagulation and the timing of its discontinuation are still unclear. Although the infection was controlled and portal vein thrombosis disappeared, careful monitoring will be required due to recurrence.
